The US Food and Drug Administration (FDA) has approved the belimumab 200 mg/mL autoinjector for children aged 5 years of older with active lupus nephritis (LN) who are receiving standard therapy.

NeuroScientific Biopharmaceuticals has ventured into stem cell therapy with a $5.1M purchase of unlisted Perth-based company ...

One of the leading causes of kidney disease in non-diabetics is high blood pressure, also called hypertension. The kidneys ...

Medically reviewed by Stella Bard, MD Lupus is a chronic autoimmune disease in which your immune system mistakenly attacks ...

The American College of Rheumatology has updated its systemic lupus erythematosus treatment guidelines for the first time ...